Pharmaceutical drugs developed by two local companies received approvals in the European Union last month. On Dec. 12, Culver ...

KBRA releases its 2026 European project finance and infrastructure (PF&I) Sector Outlook, examining themes that will likely take centre stage in 2026 as well as developments and ratings trends from ...

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or the “Company”), the world leader in listeria-based cancer ...

ExchangeWire’s 2026 line-up brings the ATS experience to four global hubs, each with its own distinct energy and industry ...

Green energy boosts job creation, attracts investment and cuts long-term costs, making it a key driver of sustainable ...

If the next generation of global industry is going to draw on Africa’s critical minerals, what scale of planning can ...

Additional proof of concept data consistent and strengthen data set shared at ASH 2025Management to host meetings at JP Morgan 44th Annual Healthcare Conference 2026 SAN FRANCISCO, CALIFORNIA / ACCESS ...

So, when will crypto be regulated? 2026 is expected to be the year when most countries will have their actual rules. If ...

Biogen has secured European regulatory approval for a high-dose regimen of its Spinraza drug for the neuromuscular disease spinal muscular atrophy, or SMA. Biogen on Monday said the European ...

CEO Matthew Prince slams Italy's Piracy Shield law for allowing ‘shadowy, European media cabal’ to dictate internet ...

European law firm Fieldfisher has further strengthened its regulatory offering in the Brussels office with the arrival of ...